BriaCell Therapeutics Corp.
BCTX
Positions held
Your positionsBCTX isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $34.10M | Enterprise value | $10.65M | Trailing P/E | — | Forward P/E | -10.05 |
| PEG | — | Price / book | 1.18 | Beta | 1.51 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -1.8% | ROA | -90.8% | Debt / equity | — |
| Current ratio | 7.07 | Free cash flow | -$20.04M | Analyst recommendation | none | Mean target | — |
| 52w high | $14.68 | 52w low | $2.60 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Op margin | — | — | — | — | — |
| Net income | -$7.2M | -$7.2M | -$8.2M | -$6.1M | -$6.3M |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$7.6M | -$7.5M | -$8.3M | -$6.3M | -$7.2M |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | — | $0.0M | $0.0M | $0.0M |
| Op margin | — | — | — | — |
| Net income | — | -$4.8M | -$20.3M | -$26.8M |
| Gross margin | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating income | — | -$33.3M | -$23.3M | -$15.3M |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-06 · BriaCell and BriaPro to Present Four Posters at SITC 2026 Annual Meeting
2026-09-14 · Data Safety Monitoring Board (DSMB) Recommends Continuing BriaCell’s Phase 3 Metastatic Breast Cancer Study
2026-09-08 · BriaCell’s Pivotal Phase 3 Metastatic Breast Cancer Study Expands to Leading Cancer Center
2026-07-16 · BriaCell Opens First Canadian Site For Phase 3 Metastatic Breast Cancer Study
2026-07-16 · BriaCell Opens First Canadian Site – Sunnybrook – for Pivotal Phase 3 Trial in Metastatic Breast Cancer
2026-07-15 · BriaCell Arranges Scalable Manufacturing with FUJIFILM Biotechnologies for Bria-IMT™
Price (daily)
Full chart · RSI · MACD · patterns